Table 2.
Start | Stop | Peptide Sequence | Phosphor-Site | Fold Change a | Log2 fold change |
---|---|---|---|---|---|
17 | 30 | WIGpSETDLEPPVVK | Ser20 | 1.88±0.20 | 0.91 |
296 | 315 | DKKpSPLIESTANMDNNQSQK | Ser299 | 0.99±0.16 | −0.01 |
296 | 315 | DKKSPLIEpSTANMDNNQSQK | Ser304 | 1.00±0.17 | 0.00 |
421 | 428 | IpSPKEEER | Ser422 | 0.85±0.17 | −0.23 |
443 | 456 | pTGSYGALAEITASK | Thr443 | 0.97±0.16 | −0.04 |
443 | 456 | TGpSYGALAEITASK | Ser445 | 1.24±0.06 | 0.31 |
476 | 483 | LpSSSLDNK | Ser477 | 10.92±2.97* | 3.45 |
476 | 483 | LSpSSLDNK | Ser478 | 4.84±1.39* | 2.28 |
505 | 514 | LApSTSDIEEK | Ser507 | 6.53±1.37* | 2.71 |
505 | 514 | LASTpSDIEEK | Ser509 | 0.48±0.08* | −1.06 |
504 | 514 | RLApSTpSDIEEK | Ser507, Ser509 | 3.49±0.61* | 1.80 |
668 | 682 | pSYLTPVRDEESESQR | Ser668 | 2.25±0.38* | 1.17 |
668 | 682 | SYLpTPVRDEESESQR | Thr671 | 0.66±0.06 | −0.60 |
668 | 682 | SYLTPVRDEEpSESQR | Ser678 | 0.60±0.11 | −0.74 |
695 | 709 | pSTQGVTLTDLQEAEK | Ser695 | 2.38±0.18* | 1.25 |
908 | 917 | SGpSYSYLEER | Ser910 | 1.19±0.20 | 0.25 |
993 | 1002 | RIpSEMEEELK | Ser995 | 1.00±0.11 | 0.00 |
Fold change: obtained by dividing the normalized peak area for a phosphopeptide in each experiment by the average of the normalized peak area under the control condition, n=6.
Indicate insulin stimulated or suppressed phosphorylation at these sites by more than 2-fold.